IRIS
BELCARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.326
AS - Asia 6.374
EU - Europa 5.849
SA - Sud America 1.248
Continente sconosciuto - Info sul continente non disponibili 498
AF - Africa 108
OC - Oceania 47
AN - Antartide 1
Totale 25.451
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.077
SG - Singapore 2.454
CN - Cina 1.682
BR - Brasile 977
UA - Ucraina 931
IE - Irlanda 903
IT - Italia 782
VN - Vietnam 702
TR - Turchia 689
RU - Federazione Russa 685
SE - Svezia 577
GB - Regno Unito 528
FR - Francia 427
DE - Germania 397
IN - India 255
FI - Finlandia 203
HK - Hong Kong 147
AR - Argentina 122
PL - Polonia 112
CA - Canada 101
MX - Messico 70
ID - Indonesia 69
BD - Bangladesh 66
ES - Italia 52
EC - Ecuador 47
JP - Giappone 43
AU - Australia 40
BE - Belgio 40
NL - Olanda 40
KR - Corea 39
ZA - Sudafrica 34
AT - Austria 31
TH - Thailandia 31
IQ - Iraq 29
CO - Colombia 27
PK - Pakistan 25
CH - Svizzera 24
CZ - Repubblica Ceca 24
IR - Iran 24
VE - Venezuela 24
PY - Paraguay 22
JM - Giamaica 18
SA - Arabia Saudita 17
PT - Portogallo 16
TN - Tunisia 16
EG - Egitto 15
TW - Taiwan 15
CR - Costa Rica 13
EU - Europa 13
JO - Giordania 12
CL - Cile 11
MY - Malesia 11
PE - Perù 11
GR - Grecia 10
LT - Lituania 10
MA - Marocco 10
NI - Nicaragua 10
PH - Filippine 10
UZ - Uzbekistan 10
HN - Honduras 8
RO - Romania 8
SK - Slovacchia (Repubblica Slovacca) 8
AE - Emirati Arabi Uniti 7
HR - Croazia 7
IL - Israele 7
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
DZ - Algeria 6
KE - Kenya 6
NP - Nepal 6
BG - Bulgaria 5
DK - Danimarca 5
KZ - Kazakistan 5
SI - Slovenia 5
SV - El Salvador 5
AL - Albania 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KW - Kuwait 4
BB - Barbados 3
ET - Etiopia 3
LU - Lussemburgo 3
OM - Oman 3
PS - Palestinian Territory 3
RS - Serbia 3
UY - Uruguay 3
CG - Congo 2
GA - Gabon 2
LB - Libano 2
MK - Macedonia 2
PA - Panama 2
SC - Seychelles 2
SO - Somalia 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
Totale 24.945
Salva come PNG Salva come JPEG
Città #
Singapore 1.726
Jacksonville 1.182
Chandler 907
Dublin 896
San Jose 804
Ashburn 560
Council Bluffs 485
Princeton 438
Dallas 414
Izmir 363
Beijing 349
Nanjing 349
Southend 346
Ho Chi Minh City 255
Santa Clara 228
Los Angeles 195
Wilmington 190
Cambridge 188
Altamura 183
Hanoi 159
Ann Arbor 129
Tongling 129
Hong Kong 123
Nanchang 120
New York 119
Dearborn 110
The Dalles 99
Moscow 89
São Paulo 75
Boardman 72
Buffalo 71
Atlanta 70
Redondo Beach 67
Kraków 65
Shenyang 63
Hebei 56
Columbus 49
Orem 49
Kunming 48
Tianjin 48
Woodbridge 45
Jiaxing 41
Munich 41
Da Nang 40
Milan 40
Phoenix 39
Rome 38
Denver 37
San Francisco 36
London 35
Warsaw 35
Catania 34
Houston 34
Tokyo 34
Boston 33
Changsha 31
Brooklyn 30
Brussels 30
Norwalk 30
Seattle 30
Rio de Janeiro 29
Washington 29
Chennai 28
Chicago 27
Memphis 27
Haiphong 26
Montreal 26
Frankfurt am Main 24
Mexico City 23
Chieti 22
Curitiba 22
Hangzhou 22
Ankara 21
Falls Church 21
Sydney 21
Toronto 21
Vienna 20
Guangzhou 19
Hefei 18
Manchester 18
Mumbai 18
Amsterdam 17
Istanbul 17
Johannesburg 17
Lanzhou 17
Belo Horizonte 16
Brno 16
Grevenbroich 16
Helsinki 16
Shanghai 16
Biên Hòa 15
Quito 15
San Mateo 15
Guayaquil 14
Hải Dương 14
Jinan 14
Philadelphia 14
Bangkok 13
Dhaka 13
Foggia 13
Totale 13.351
Salva come PNG Salva come JPEG
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 640
Xerostomia: prevention with Pycnogenol® supplementation: a pilot study. 543
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 431
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 351
Pycnogenol may alleviate adverse effects in oncologic treatment 331
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 329
Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study 302
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 248
Oral administration of a lecithin-based delivery form of boswellic acids (Casperome®) for the prevention of symptoms of irritable bowel syndrome: A randomized clinical study. 222
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 216
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 204
Improvement of common cold with Pycnogenol®: a Winter registry study 192
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 187
Prevention of edema in long flights with Pycnogenol 178
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 174
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 171
Lady Prelox® improves sexual function in post-menopausal women 171
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 160
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 160
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 159
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 158
Robuvit®: improvement of fatigue in medical convalescence. 158
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 158
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 156
Topical heparin: New observations 149
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 147
Postoperative pulmonary infections: role of antibiotic treatment 146
Mononucleosis-related fatigue: supplementary management with Robuvit®. 146
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 146
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 145
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 143
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 142
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 142
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 141
Prevention of influenza episodes with colostrum compared with vaccination in healthy and high-risk cardiovascular subjects: the epidemiologic study in San Valentino 141
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 141
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 141
A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study 140
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 138
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 137
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 136
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 136
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 135
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 134
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 134
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 133
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 133
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 133
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 133
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 133
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 132
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 131
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 130
Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study. 129
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 129
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 129
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 129
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers. 128
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 127
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 126
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 126
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 126
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 126
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 124
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 124
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 124
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 124
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 124
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 123
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 123
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 123
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 122
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 122
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 120
Improvement in signs and symptoms in psoriasis patients with Pycnogenol® supplementation. 120
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 119
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 119
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 119
Supplementation with Pycnogenol® improves signs and symptoms of menopausal transition. 118
Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere's disease and tinnitus 118
Improvement of common cold with Pycnogenol®: a Winter registry study. 117
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 116
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]. 116
Local heparin, superficial vein thrombosis 116
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 115
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 114
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 114
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 114
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 113
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 113
Computerized ultrasonic angiography. Current applications and comparison with other noninvasive and invasive methods 112
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 112
A plaster combining diclofenac and heparin: microcirculatory evaluation in 2 models of high-perfusion microangiopathy 111
Oxidative stress following administration of levothyroxine in subjects suffering from primary hypothyroidism. 111
A controlled study of a lecithinized delivery system of curcumin (Meriva®) to alleviate the adverse effects of cancer treatment 111
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 110
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 110
Episodic primary migraine headache: prophylaxis with Pycnogenol® precents attacks and controls oxidative stress. 110
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 109
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 109
Totale 15.611
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022836 0 0 15 166 77 25 19 65 68 17 101 283
2022/20232.720 272 406 156 284 234 570 180 176 276 26 88 52
2023/20241.146 88 50 65 26 48 287 334 38 24 50 33 103
2024/20253.392 264 688 530 55 78 93 64 149 394 147 281 649
2025/20267.382 486 302 956 1.378 544 367 886 504 724 543 447 245
2026/20273.107 841 1.652 614 0 0 0 0 0 0 0 0 0
Totale 25.451